Lymphatic Regulation of Skin Electrolyte Metabolism and Blood Pressure
皮肤电解质代谢和血压的淋巴调节
基本信息
- 批准号:9277247
- 负责人:
- 金额:$ 25.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-07-24 至 2019-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAnimalsBindingBloodBlood PressureBlood VesselsBody FluidsBuffersCationsCellsClinicalCutaneousDataElectrolytesEquilibriumEssential HypertensionEtiologyExcretory functionExtracellular FluidExtracellular SpaceFailureGene ExpressionGeneticGoalsHeartHomeostasisHumanHyperplasiaHypertensionImmuneImmunological ModelsKidneyKidney FailureLaboratoriesLymphLymphaticLymphatic CapillariesMetabolicMetabolismModelingModificationMusMyocardial InfarctionNOS3 geneNeuraxisOsmotic ActivityParticipantPilot ProjectsPre-Clinical ModelPromoter RegionsRegulationResearchRisk FactorsSiteSkinSodium ChlorideStreamStressStrokeSystemic blood pressureTestingTissuesUrineVEGFC geneVascular Endothelial Growth Factor CWaterWorkblood pressure regulationcardiovascular disorder riskcardiovascular risk factordensitydietary saltdriving forceenhancer binding proteinexperimental studyextracellularin vivointerstitialmacrophagemetabolic abnormality assessmentprogramspublic health relevancereceptorreceptor bindingresponsesalt intakesensorsubcutaneoustranscription factor
项目摘要
DESCRIPTION (provided by applicant): Primary essential hypertension is the major cardiovascular disease risk factor. Dietary salt intake is a putative driving force of blood pressure elevation; however, the mechanisms of this effect remain unclear. The central nervous system, heart and blood vessels, and kidney are primary participants and the kidney is the putative grand regulator of salt disposition and blood pressure. The overall goal of this work is t address whether or not local regulation of skin electrolyte metabolism is important for blood pressure control. Clinical evidence from pilot studies in humans and preliminary experimental data accumulated in our laboratory, support this hypothesis. Our data point to macrophage-derived vascular endothelial growth factor C (VEGF-C) as a crucial factor controlling skin electrolyte homeostasis. VEGF-C promotes interstitial electrolyte clearance through the cutaneous lymph capillary network. Macrophages induce hyperplasia of subcutaneous lymph capillaries after sensing local Na+ or Cl- overload in the interstitium. The sensing function is accomplished by binding of the transcription factor tonicity-enhancer binding protein (TonEBP) to the promoter region of the VEGF-C gene. The cells exert their regulatory function by increasing VEGF-C expression and secretion. Blockade of this VEGF-C response from macrophages leads to skin electrolyte accumulation and arterial hypertension. We propose a comprehensive program to characterize the importance of TonEBP for macrophage-driven lymphatic regulation of skin electrolyte homeostasis in vivo (Aim 1). We will address whether or not disruption of subcutaneous lymph capillaries by selective VEGF-C depletion in the skin will lead to specific changes in skin electrolyte composition and increase blood pressure systemically (Aim 2). Finally, we will test whether macrophage-derived VEGF-C exerts its blood pressure-lowering effect via receptor binding to blood vessels, or by binding to cutaneous lymph vessels (Aim 3).
描述(由申请人提供):主要基本高血压是主要的心血管疾病危险因素。饮食盐的摄入量是血压升高的推定驱动力。但是,这种作用的机制尚不清楚。中枢神经系统,心脏和血管以及肾脏是主要参与者,肾脏是盐处置和血压的假定大调节剂。这项工作的总体目标是解决皮肤电解质代谢的局部调节是否对血压控制很重要。来自人类试点研究的临床证据以及我们实验室中积累的初步实验数据支持这一假设。我们的数据指向巨噬细胞衍生的血管内皮生长因子C(VEGF-C)是控制皮肤电解质稳态的关键因素。 VEGF-C通过皮肤淋巴毛细血管网络促进间质电解质清除率。巨噬细胞诱导皮下淋巴毛细血管的增生,在感觉局部Na+或间质中cl-过载后。传感函数是通过结合转录因子增强性增强蛋白(ToneBP)与VEGF-C基因启动子区域的结合来实现的。细胞通过增加VEGF-C表达和分泌来发挥其调节功能。巨噬细胞对这种VEGF-C反应的封锁导致皮肤电解质的积累和动脉高血压。我们提出了一个综合计划,以表征ToneBP对体内皮肤电解质稳态的巨噬细胞驱动淋巴调节的重要性(AIM 1)。我们将解决皮肤中选择性VEGF-C耗竭对皮下淋巴毛细血管的破坏是否会导致皮肤电解质组成的特定变化并系统地增加血压(AIM 2)。最后,我们将测试巨噬细胞来源的VEGF-C是通过与血管结合或与皮肤淋巴管结合的受体结合而降低血压的作用(AIM 3)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jens Marc Titze其他文献
Jens Marc Titze的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jens Marc Titze', 18)}}的其他基金
Tissue Sodium, Inflammation, and Blood Pressure in MESA
MESA 中的组织钠、炎症和血压
- 批准号:
9340012 - 财政年份:2016
- 资助金额:
$ 25.14万 - 项目类别:
Lymphatic Regulation of Skin Electrolyte Metabolism and Blood Pressure
皮肤电解质代谢和血压的淋巴调节
- 批准号:
9851478 - 财政年份:2013
- 资助金额:
$ 25.14万 - 项目类别:
Lymphatic Regulation of Skin Electrolyte Metabolism and Blood Pressure
皮肤电解质代谢和血压的淋巴调节
- 批准号:
8483861 - 财政年份:2013
- 资助金额:
$ 25.14万 - 项目类别:
Lymphatic Regulation of Skin Electrolyte Metabolism and Blood Pressure
皮肤电解质代谢和血压的淋巴调节
- 批准号:
8706227 - 财政年份:2013
- 资助金额:
$ 25.14万 - 项目类别:
Defining immune footprint in tumor microenvironment following high salt synergized inflammatory cytokine mediated breast cancer progression
定义高盐协同炎症细胞因子介导的乳腺癌进展后肿瘤微环境中的免疫足迹
- 批准号:
9356480 - 财政年份:
- 资助金额:
$ 25.14万 - 项目类别:
Defining immune footprint in tumor microenvironment following high salt synergized inflammatory cytokine mediated breast cancer progression
定义高盐协同炎症细胞因子介导的乳腺癌进展后肿瘤微环境中的免疫足迹
- 批准号:
9767532 - 财政年份:
- 资助金额:
$ 25.14万 - 项目类别:
Defining immune footprint in tumor microenvironment following high salt synergized inflammatory cytokine mediated breast cancer progression
定义高盐协同炎症细胞因子介导的乳腺癌进展后肿瘤微环境中的免疫足迹
- 批准号:
9210833 - 财政年份:
- 资助金额:
$ 25.14万 - 项目类别:
相似国自然基金
熏蒸结合动物堆肥对土壤-蔬菜系统抗生素抗性基因的影响机制
- 批准号:42307033
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
无菌动物模型与单细胞拉曼技术结合的猴与人自闭症靶标菌筛选及其机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
无菌动物模型与单细胞拉曼技术结合的猴与人自闭症靶标菌筛选及其机制研究
- 批准号:82201339
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
一种新型PRC1变体在不同细胞类型中的结合动态与功能研究
- 批准号:31900422
- 批准年份:2019
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
多配体协同作用对铬在动物皮内的渗透-结合性能和交联强度的调控机制及应用
- 批准号:21908149
- 批准年份:2019
- 资助金额:26.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Endothelial Cell Reprogramming in Familial Intracranial Aneurysm
家族性颅内动脉瘤的内皮细胞重编程
- 批准号:
10595404 - 财政年份:2023
- 资助金额:
$ 25.14万 - 项目类别:
Dravet Syndrome Anti-Epileptic Control by Targeting GIRK Channels
通过针对 GIRK 通道进行 Dravet 综合征抗癫痫控制
- 批准号:
10638439 - 财政年份:2023
- 资助金额:
$ 25.14万 - 项目类别:
Ceramides as Novel Mediators of Tubular Metabolic Dysfunction Driving Kidney Injury
神经酰胺作为肾小管代谢功能障碍驱动肾损伤的新型调节剂
- 批准号:
10677394 - 财政年份:2023
- 资助金额:
$ 25.14万 - 项目类别:
Develop an engineered Cas effector for in vivo cell-targeted delivery in the eye to treat autosomal dominant BEST disease
开发工程化 Cas 效应器,用于眼内体内细胞靶向递送,以治疗常染色体显性 BEST 疾病
- 批准号:
10668167 - 财政年份:2023
- 资助金额:
$ 25.14万 - 项目类别:
Illumination of TAAR2 Location, Function and Regulators
TAAR2 位置、功能和调节器的阐明
- 批准号:
10666759 - 财政年份:2023
- 资助金额:
$ 25.14万 - 项目类别: